Targeting CSF-1R repolarizes M2-like TAMs to the M1 phenotype, reduces the infiltration of macrophages into tumor tissue, and improves patients’ response to standard treatment in mouse ovarian tumor models and ovarian cancer patients [170]. Here, CSF1R is linked to neoplasm.